DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Connacht's slim BKT URC play-off hopes were ended as they lost 31-21 to Edinburgh at the Dexcom Stadium. Needing two wins and ...

Edinburgh hold an edge in this fixture with 20 wins from 37 meetings which includes 15 Connacht triumphs and two draws.

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins. Check out why I am lowering my rating on DXCM from buy to hold.

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) ...

Lantz uses the Dexcom glucose monitor for her Type 1 diabetes and has joined the Dexcom U team, an NIL that helps athletes ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

DexCom Inc. closed 38.36% below its 52-week high of $132.26, which the company reached on May 17th.

Ōura, maker of a health-monitoring smart ring, announced that it will use AI to track and analyze two new metabolic health features: meals and glucose.

Glucose tracking is a natural part of Oura’s $75 million investment from Dexcom.

The Oura Ring 4 is rapidly becoming the center piece of your efforts to lead a healthier life, and the introduction of two new features designed to improve metabolic health back this up. The app now ...